Actinium Newsroom

Ariceum Therapeutics and Eckert & Ziegler Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments

PR NewswireDec 5 03:30 ET

Actinium Pharmaceuticals 2024 Stockholder Meeting Outcomes

TipRanksNov 27 17:01 ET

Express News | Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)

ReutersNov 21 08:05 ET

NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)

BusinesswireNov 21 08:00 ET

Maxim Group Maintains Actinium(ATNM.US) With Buy Rating, Announces Target Price $5

Moomoo NewsNov 20 13:31 ET · Ratings

Stephens Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsNov 19 12:31 ET · Ratings

Actinium Pharmaceuticals Continues R&D Focus Amid Financial Progress

TipRanksNov 18 23:03 ET

Express News | SK Biopharmaceuticals Seals 1St Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

ReutersNov 18 19:00 ET

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

PR NewswireNov 18 19:00 ET

Actinium Highlights Development Updates for Iomab-B, Actimab-A, Iomab-ACT

TipRanksNov 18 08:17 ET

Express News | Actinium Pharmaceuticals Q3 EPS $(0.37) Misses $(0.30) Estimate

BenzingaNov 18 08:13 ET

Actinium Pharmaceuticals 3Q Loss $11.6M >ATNM

Dow JonesNov 18 08:06 ET

Actinium Pharma Actively Seeking Strategic Partner for Iomab-B in U.S.

Dow JonesNov 18 08:06 ET

Actinium Pharma Doesn't Expect Departures to Have Material Impact on Ops >ATNM

Dow JonesNov 18 08:06 ET

Actinium Pharmaceuticals Overall Headcount Reduced by About 20% in 3Q

Dow JonesNov 18 08:05 ET

Actinium Pharma: Cash and Cash Equivalents of About $78.6 M as of Sept 30 Expected to Fund Ops Into 2027 >ATNM

Dow JonesNov 18 08:04 ET

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024

PR NewswireNov 18 08:00 ET

Actinium Pharma Analyst Ratings

BenzingaNov 15 14:13 ET · Ratings

H.C. Wainwright Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsNov 15 10:32 ET · Ratings

Actinium | 10-Q: Q3 2024 Earnings Report

SECNov 14 17:02 ET · Announcements